<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:47:15Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3563981" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:3563981</identifier><datestamp>2013-02-05</datestamp><setSpec>cddis</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Cell Death Dis</journal-id>
      <journal-id journal-id-type="iso-abbrev">Cell Death Dis</journal-id>
      <journal-title-group>
        <journal-title>Cell Death &amp; Disease</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2041-4889</issn>
      <publisher>
        <publisher-name>Nature Publishing Group</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC3563981</article-id>
      <article-id pub-id-type="pmcid">PMC3563981</article-id>
      <article-id pub-id-type="pmc-uid">3563981</article-id>
      <article-id pub-id-type="pmid">23303127</article-id>
      <article-id pub-id-type="pii">cddis2012193</article-id>
      <article-id pub-id-type="doi">10.1038/cddis.2012.193</article-id>
      <article-id pub-id-type="pmid">23303127</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Selective glucocorticoid receptor translational isoforms reveal glucocorticoid-induced apoptotic transcriptomes</article-title>
        <alt-title alt-title-type="running">Glucocorticoid receptor isoforms and apoptosis</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>I</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="author-notes" rid="note1">
            <sup>5</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shin</surname>
            <given-names>S C</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cao</surname>
            <given-names>Y</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bender</surname>
            <given-names>I K</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jafari</surname>
            <given-names>N</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Feng</surname>
            <given-names>G</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>S</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
          <xref ref-type="author-notes" rid="note2">
            <sup>6</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cidlowski</surname>
            <given-names>J A</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schleimer</surname>
            <given-names>R P</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lu</surname>
            <given-names>N Z</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="caf1">*</xref>
        </contrib>
        <aff id="aff1"><label>1</label><institution>Division of Allergy-Immunology, Department of Medicine, Feinberg School of Medicine, Northwestern University</institution>, Chicago, IL, <country>USA</country></aff>
        <aff id="aff2"><label>2</label><institution>Genomics Core Facility</institution>, Chicago, IL, <country>USA</country></aff>
        <aff id="aff3"><label>3</label><institution>Biomedical Informatics Center, Feinberg School of Medicine, Northwestern University</institution>, Chicago, IL, <country>USA</country></aff>
        <aff id="aff4"><label>4</label><institution>Laboratory of Signal Transduction, NIEHS, NIH</institution>, Research Triangle Park, NC, <country>USA</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="caf1"><label>*</label><institution>Division of Allergy-Immunology, Department of Medicine, Feinberg School of Medicine, Northwestern University</institution>, McGaw, Room M301, 240 East Huron, Chicago, IL 60611, <country>USA</country>. Tel: +312 503 1310; Fax: +312 503 0078; E-mail: <email>nickzlu@northwestern.edu</email></corresp>
        <fn fn-type="present-address" id="note1">
          <label>5</label>
          <p>Current address: Department of Anesthesiology, College of Physicians and Surgeons, Columbia University, NY City, NY, USA.</p>
        </fn>
        <fn fn-type="present-address" id="note2">
          <label>6</label>
          <p>Current address: Biomedical Informatics Research Center, Marshfield Clinic Research Foundation, Marshfield, WI, USA.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>01</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>10</day>
        <month>01</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>1</day>
        <month>1</month>
        <year>2013</year>
      </pub-date>
      <volume>4</volume>
      <issue>1</issue>
      <fpage>e453</fpage>
      <lpage/>
      <history>
        <date date-type="received">
          <day>09</day>
          <month>10</month>
          <year>2012</year>
        </date>
        <date date-type="rev-recd">
          <day>26</day>
          <month>11</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>11</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright Â© 2013 Macmillan Publishers Limited</copyright-statement>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Macmillan Publishers Limited</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">
          <!--author-paid-->
          <license-p>This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Induction of T-cell apoptosis contributes to the anti-inflammatory and antineoplastic benefits of glucocorticoids. The glucocorticoid receptor (GR) translational isoforms have distinct proapoptotic activities in osteosarcoma cells. Here we determined whether GR isoforms selectively induce apoptosis in Jurkat T lymphoblastic leukemia cells. Jurkat cells stably expressing individual GR isoforms were generated and treated with vehicle or dexamethasone (DEX). DEX induced apoptosis in cells expressing the GR-A, -B, or -C, but not the GR-D, isoform. cDNA microarray analyses of cells sensitive (GR-C3) and insensitive (GR-D3) to DEX revealed glucocorticoid-induced proapoptotic transcriptomes. Genes that were regulated by the proapoptotic GR-C3, but not by the GR-D3, isoform likely contributed to glucocorticoid-induced apoptosis. The identified genes include those that are directly involved in apoptosis and those that facilitate cell killing. Chromatin immunoprecipitation assays demonstrated that distinct chromatin modification abilities may underlie the distinct functions of GR isoforms. Interestingly, all GR isoforms, including the GR-D3 isoform, suppressed mitogen-stimulated cytokines. Furthermore, the GR-C isoforms were selectively upregulated in mitogen-activated primary T cells and DEX treatment induced GR-C target genes in activated T cells. Cell-specific expressions and functions of GR isoforms may help to explain the tissue- and individual-selective actions of glucocorticoids and may provide a basis for developing improved glucocorticoids.</p>
      </abstract>
      <kwd-group>
        <kwd>glucocorticoid</kwd>
        <kwd>glucocorticoid receptor</kwd>
        <kwd>apoptosis</kwd>
        <kwd>T cell</kwd>
        <kwd>alternative translation</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Glucocorticoids are frequently used in the treatment of inflammatory conditions such as asthma, transplant rejection, and autoimmune disorders, as well as certain cancers such as Hodgkin's lymphoma, multiple myeloma, and acute lymphoblastic leukemia (ALL).<sup><xref ref-type="bibr" rid="bib1">1</xref></sup> The anti-inflammatory and antineoplastic actions of glucocorticoids can be partially attributed to glucocorticoid-induced apoptosis.<sup><xref ref-type="bibr" rid="bib1">1</xref></sup> Glucocorticoids activate their cognate receptor, the glucocorticoid receptor (GR), that can upregulate proapoptotic genes and downregulate antiapoptotic genes. Proapoptotic B-cell CLL/lymphoma 2 (BCL-2)-associated agonist of cell death (BAD), BCL-2-interacting mediator of cell death (BIM, BCL2L11), and BCL-2-associated X protein (BAX)<sup><xref ref-type="bibr" rid="bib2">2</xref>, <xref ref-type="bibr" rid="bib3">3</xref>, <xref ref-type="bibr" rid="bib4">4</xref></sup> are induced and prosurvival BCL-2 and BCL-XL proteins are reduced<sup><xref ref-type="bibr" rid="bib5">5</xref>, <xref ref-type="bibr" rid="bib6">6</xref></sup> in T cells by glucocorticoids. It has been proposed that the balance between pro- and antiapoptotic factors regulated by glucocorticoids defines the apoptotic threshold of a cell.<sup><xref ref-type="bibr" rid="bib7">7</xref></sup> Careful analyses have revealed that multiple candidate genes may underlie glucocorticoid-induced apoptosis in ALL cells.<sup><xref ref-type="bibr" rid="bib8">8</xref>, <xref ref-type="bibr" rid="bib9">9</xref></sup></p>
    <p>Despite the wide range of gene targets of the GR, only one single <italic>GR</italic> gene has been discovered to date. This single <italic>GR</italic> gene generates several GR isoforms, however, including GR<italic>Î±</italic> and <italic>Î²</italic> via alternative splicing, with GR<italic>Î±</italic> being expressed at relatively higher levels in the majority of tissues examined.<sup><xref ref-type="bibr" rid="bib10">10</xref></sup> We have reported that each GR transcript generates additional isoforms via alternative translation initiation mechanisms.<sup><xref ref-type="bibr" rid="bib11">11</xref></sup> Ribosomal leaky scanning and ribosomal shunting are responsible for the GR<italic>Î±</italic>-A, -B, -C1, -C2, -C3, -D1, -D2, and -D3 isoforms. These GR(<italic>Î±</italic>) isoforms have distinct tissue distribution patterns.<sup><xref ref-type="bibr" rid="bib11">11</xref></sup> Pancreas and colon have the highest amount of the GR-C isoforms, whereas spleen and lungs have the highest amount of the GR-D isoforms. When individual GR isoforms were expressed at comparable levels in U-2 OS cells, an osteosarcoma cell line lacking endogenous GR, they regulated unique sets of genes and mediated glucocorticoid-induced apoptosis in distinct manners.<sup><xref ref-type="bibr" rid="bib12">12</xref></sup> The GR-C3 (a representative of C1, C2, and C3) isoform has enhanced activity as demonstrated by the earlier onset and higher percentage of cell death in GR-C3 isoform-expressing cells compared with cells expressing other GR isoforms, whereas GR-D3 (a representative of the D1, D2, and D3) isoform-expressing cells are insensitive to glucocorticoid killing. The GR-C3 isoform induces the expression of proapoptotic molecules, such as granzyme A (GZMA), more efficiently than the GR-D3 isoform. It was also found that the GR-C3 isoform recruits coactivators, acetylates histone H4, and recruits activated RNA polymerase II more efficiently than the GR-D3 isoform on GZMA promoter.<sup><xref ref-type="bibr" rid="bib12">12</xref></sup></p>
    <p>To further identify the physiological functions of GR translational isoforms, we produced stable clones of Jurkat cells expressing individual GR isoforms and examined the apoptosis-inducing activity of individual GR isoforms. As in U-2 OS cell lines, dexamethasone (DEX), a potent glucocorticoid, induced apoptosis most efficiently in Jurkat cells expressing the GR-C3 isoform, whereas the GR-D3 isoform-expressing cells were resistant to glucocorticoid killing. Thus, a new model system to identify genes mediating glucocorticoid-induced apoptosis was established. The GR-C-sensitive and GR-D-insensitive genes are likely mediators for glucocorticoid-induced apoptosis. In addition, we found that components of cytoskeleton may facilitate glucocorticoid-induced apoptosis. Furthermore, activated primary T cells selectively increased the expression of the GR-C isoforms and certain GR-C target genes. These studies improve our understanding of the role of GR isoforms in apoptosis and in regulation of Jurkat and primary T cells and may provide a basis for the development of new anti-inflammatory and antineoplastic glucocorticoids.</p>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>Selective GR translational isoforms induce apoptosis in Jurkat cells</title>
        <p>Individual GR isoforms were stably transfected into Jurkat (clone E6.1) cells. This parental clone is resistant to glucocorticoid killing due to low expression of endogenous GR.<sup><xref ref-type="bibr" rid="bib13">13</xref></sup> The expression level of individual GR isoforms among stable clones was comparable to that of the endogenous GR level in CEM-7 cells, another T ALL cell line (<xref ref-type="fig" rid="fig1">Figure 1</xref>). DEX treatment for 48âh killed approximately 30% of the cells expressing the GR<italic>Î±</italic>, -A, or -B isoforms and up to 50% of the cells expressing the GR-C3 isoform, whereas the GR-D3 isoform-expressing cells were insensitive to DEX killing. Correspondingly, various apoptotic markers, including Annexing-V labeling, DNA degradation, and poly ADP-ribose polymerase (PARP) cleavage, were induced most efficiently by the GR-C isoform followed by the GR<italic>Î±</italic>, -A, and -B isoforms. The induction of apoptosis markers by the GR-D3 isoform was minimal, although detectable, and significantly less than that by the GR<italic>Î±</italic>. The selective apoptosis-inducing activity of GR isoforms in Jurkat cells confirmed the observations made previously in two sets of osteoblast U-2 OS clones.<sup><xref ref-type="bibr" rid="bib12">12</xref></sup></p>
      </sec>
      <sec>
        <title>Selective GR translational isoforms inhibit MYC</title>
        <p>We hypothesized that the GR isoform-selective apoptosis-inducing activity is due to selective regulation of apoptotic factors by the apoptosis-inducing GR isoforms, for example, the GR-C3 isoform, distinctly from the GR-D3 isoform. To test this, we determined the regulation of several previously reported mediators of glucocorticoid-induced apoptosis by these GR isoforms. The proto-oncogene v-myc myelocytomatosis viral oncogene homolog (avian, MYC) has been demonstrated to promote the survival and proliferation of both Jurkat and normal T cells.<sup><xref ref-type="bibr" rid="bib14">14</xref></sup> Overexpression of MYC inhibits, whereas repression of MYC enhances, glucocorticoid-induced apoptosis of CEM cells.<sup><xref ref-type="bibr" rid="bib15">15</xref></sup> The DEX-mediated repression of MYC was significantly more effective by GR<italic>Î±</italic>, -A, -B, or -C3 isoform than by the GR-D3 isoform (<xref ref-type="fig" rid="fig2">Figure 2a</xref>). MYC suppression by DEX in GR-C3 or -A isoform-expressing cells occurred as early as 2âh after DEX exposure, whereas in GR-D3 isoform-expressing cells, MYC protein was not significantly reduced 24âh after DEX treatment (<xref ref-type="fig" rid="fig2">Figure 2b</xref>). Consistent with previous reports that MYC is antiapoptotic in ALL cells,<sup><xref ref-type="bibr" rid="bib14">14</xref></sup> ectopic expression of MYC in GR-C3-expressing cells protected, whereas knockdown of MYC in GR-D3-expressing cells sensitized the cells to DEX killing (<xref ref-type="fig" rid="fig2">Figure 2c</xref>). MYC is suppressed by DEX at the transcriptional level.<sup><xref ref-type="bibr" rid="bib16">16</xref></sup> Using chromatin immunoprecipitation (ChIP) analyses of the MYC gene regulatory region, we found that all GR isoforms bound to the inverse repeat negative glucocorticoid response elements (IR-GRE)<sup><xref ref-type="bibr" rid="bib17">17</xref></sup> in the presence of DEX (<xref ref-type="fig" rid="fig2">Figures 2d and e</xref>). Consistent with the observation that DEX did not significantly inhibit the expression of MYC in GR-D3 isoform-expressing cells, histone H4 acetylation and recruitment of polymerase II on IR-GRE were not changed by DEX treatment in GR-D3 cells (<xref ref-type="fig" rid="fig2">Figure 2f</xref>), in contrast to the observations in GR-B and -C3 cells. Histone H4 acetylation and/or recruitment of polymerase II on IR-GRE were not changed by DEX treatment in GR<italic>Î±</italic> and GR-A cells, suggesting that DEX repression of MYC in these cells are mediated by additional GREs and/or cofactors.</p>
      </sec>
      <sec>
        <title>Selective GR translational isoforms regulate proapoptotic BIM and certain microRNAs</title>
        <p>BIM is a proapoptotic BH3-only member of the BCL-2 family that activates BAX and neutralizes BCL2-like antiapoptotic proteins.<sup><xref ref-type="bibr" rid="bib18">18</xref>, <xref ref-type="bibr" rid="bib19">19</xref></sup> It has been demonstrated that BIM induction is necessary for glucocorticoid-induced cell death in mouse thymocytes and CEM cells.<sup><xref ref-type="bibr" rid="bib3">3</xref>, <xref ref-type="bibr" rid="bib20">20</xref>, <xref ref-type="bibr" rid="bib21">21</xref>, <xref ref-type="bibr" rid="bib22">22</xref>, <xref ref-type="bibr" rid="bib23">23</xref></sup> We found that the induction of BIM was significantly more effective by the GR-C3 isoform than by the GR-D3 isoform (<xref ref-type="fig" rid="fig3">Figure 3</xref>). BIM-S (the most potent proapoptotic BIM isoform) and BIM-L were induced by the GR-C3 isoform significantly more than by the GR-D3 isoform.</p>
        <p>Certain microRNAs (miRNAs) have recently been implicated in glucocorticoid-induced apoptosis.<sup><xref ref-type="bibr" rid="bib24">24</xref>, <xref ref-type="bibr" rid="bib25">25</xref>, <xref ref-type="bibr" rid="bib26">26</xref>, <xref ref-type="bibr" rid="bib27">27</xref></sup> Consistent with the literature, we found in our Jurkat model that the potentially proapoptotic miR-15b was selectively increased by DEX in the GR-C3 isoform-expressing cells, whereas in GR-D3 cells, miR15b was not induced (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure 1</xref>). In contrast, the putative antiapoptotic miR-17 was decreased in the GR-C3, but not in the GR-D3 isoform-expressing cells by DEX. GR isoform-selective regulation of miRNAs is target-specific as miR-195 was upregulated by both GR isoforms and let-7a was not regulated by either GR isoforms in this Jurkat model system.</p>
      </sec>
      <sec>
        <title>Using GR translational isoforms to identify novel apoptosis mediators</title>
        <p>Glucocorticoid-induced apoptosis in T cells is likely a multifactor-mediated event. Various mediators likely trigger apoptosis in a coordinated manner as knockdown of key mediators such as BIM<sup><xref ref-type="bibr" rid="bib3">3</xref>, <xref ref-type="bibr" rid="bib20">20</xref>, <xref ref-type="bibr" rid="bib21">21</xref>, <xref ref-type="bibr" rid="bib22">22</xref>, <xref ref-type="bibr" rid="bib23">23</xref></sup> or overexpression of MYC<sup><xref ref-type="bibr" rid="bib15">15</xref></sup> only partially reduces the glucocorticoid sensitivity. To identify additional mediators of GR isoform-selective induction of apoptosis, cDNA microarray analyses of gene targets of the GR-C3 and GR-D3 isoforms were performed using the Jurkat model system. In all, 35 genes previously reported to be involved in mediating apoptosis, based on Gene Ontology (GO: 0043067, regulation of programmed cell death), were found to be regulated (25 induced and 10 repressed) by the GR-C3, but not by the GR-D3, isoform (<xref rid="tbl1" ref-type="table">Table 1</xref>). Among the induced genes are <italic>death-associated protein-like 1</italic> (<italic>DAPL1</italic>), <italic>tumor necrosis factor receptor superfamily, member 21</italic> (<italic>TNFRSF21, TNF-related death receptor-6</italic>), <italic>inhibitor of growth family, member 1</italic> (<italic>ING1</italic>), <italic>GZMA</italic>, and <italic>BIM</italic>. In contrast, antiapoptotic molecules, such as MYC, pim-3 oncogene (PIM3), and cyclin-dependent kinase inhibitor 2D (CDKN2D or p19), were suppressed more by the GR-C3 isoform than by the GR-D3 isoform. A small number of genes (e.g., <italic>BIRC3</italic> and <italic>FAIM</italic> in <xref rid="tbl1" ref-type="table">Table 1</xref>) previously thought to be antiapoptotic were found to be induced by the GR-C3 isoform, suggesting that if these genes were antiapoptotic in Jurkat cells, their induction was overpowered by the proapoptotic programming. Real-time RT-PCR was performed to verify the observations from microarray studies (<xref ref-type="fig" rid="fig4">Figure 4</xref>). In addition, we determined the ability of GR-A to regulate genes involved in apoptosis along with the GR-C3 and GR-D3 isoforms. Reflecting the proapoptotic potency, the GR-C3 isoform appeared to be as effective as the GR-A isoform in upregulating proapoptotic ING1, whereas the GR-C3 isoform was most effective in inhibiting antiapoptotic PIM3. Seven of the 35 genes regulated uniquely by the GR-C3 isoform in Jurkat cells were also regulated in U-2 OS cells expressing the GR-C3 isoform.<sup><xref ref-type="bibr" rid="bib12">12</xref></sup> They are <italic>A kinase anchor protein 13</italic> (<italic>AKAP13</italic>), <italic>autophagy-related 12 homolog</italic> (<italic>Saccharomyces cerevisiae</italic>) (<italic>ATG12</italic>), <italic>CDKN2D</italic>, <italic>GZMA</italic>, <italic>ING1</italic>, <italic>inositol 1,4,5-triphosphate receptor, type 1</italic> (<italic>ITPR1</italic>), and <italic>SATB homeobox 1</italic> (<italic>SATB1</italic>). Whereas proteins encoded by these genes may have a role in glucocorticoid-induced apoptosis in multiple cell types, the majority of the apoptosis-related genes were uniquely regulated in either Jurkat or U-2 OS cells.</p>
        <p>Over 200 additional targets were regulated selectively by the GR-C3, but not by the GR-D3, isoform. These additional genes encode mediators of cell cycle, gene expression, cellular metabolism, signaling, cytoskeleton, and cell structure (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table 1</xref>). These genes could have a role in glucocorticoid-induced apoptosis as they were selectively regulated by the proapoptotic GR-C3 isoform. These additional mediators could disturb cell signaling or gene expression or they could have a facilitatory role in apoptosis. For example, microtubule organization has been suggested to have a role in apoptosis. Disturbance of microtubules upregulates the proapoptotic proteins BAD, BCL-2-binding component 3 (BBC3, PUMA), BAX, and BCL-2 antagonist/killer,<sup><xref ref-type="bibr" rid="bib28">28</xref>, <xref ref-type="bibr" rid="bib29">29</xref></sup> and activates BAX through the induction of conformational change.<sup><xref ref-type="bibr" rid="bib28">28</xref>, <xref ref-type="bibr" rid="bib30">30</xref></sup></p>
        <p>We found that multiple components of the cytoskeleton system were selectively regulated by the GR-C3, but not by the GR-D3, isoform. Three members of the tubulin family, <italic>Î±</italic>-tubulin (TUBA)3D, TUBA3E, and TUBA4A, belong to this GR-C3 isoform-selective category. We further investigated the mechanisms of the selective regulation and potential role in apoptosis of TUBA3E. Real-time RT-PCR experiments confirmed that TUBA3E mRNA was induced in GR-C3, but not in GR-D3 or GR-A, isoform-expressing cells (<xref ref-type="fig" rid="fig4">Figures 4</xref> and <xref ref-type="fig" rid="fig5">5</xref>). The induction of TUBA3E mRNA by the GR-C3 isoform does not require <italic>de novo</italic> protein synthesis as cycloheximide addition did not inhibit the induction (data not shown). To examine the role of TUBA3E in GR-C3 isoform-induced apoptosis, we used vector-based shRNAs to knockdown TUBA3E in the GR-C3 isoform-expressing cells (<xref ref-type="fig" rid="fig5">Figure 5a</xref>). Glucocorticoid sensitivity was compared among two separate stable clones expressing TUBA3E shRNA vectors and one clone expressing the empty vector. All three clones had equal amounts of cell death after DEX treatment despite approximately 60â90% reduction of TUBA3E mRNA levels by TUBA3E shRNA (<xref ref-type="fig" rid="fig5">Figure 5b</xref>). These results indicate that TUBA3E upregulation was not necessary for the GR-C3 isoform-induced apoptosis. To determine whether TUBA3E is facilitatory to apoptosis, we overexpressed TUBA3E in the GR-D3 isoform-expressing cells (<xref ref-type="fig" rid="fig5">Figure 5a</xref>). Overexpression of TUBA3E alone did not induce apoptosis in GR-D3 isoform-expressing cells compared with control vector-expressing cells (<xref ref-type="fig" rid="fig5">Figure 5b</xref>). However, in the presence of DEX, GR-D3 isoform-expressing cells became sensitive to glucocorticoid-killing. These results indicate that TUBA3E, even though not an initiator of apoptosis, facilitates the completion of apoptosis. Furthermore, the hypothesis that TUBA3E has unique functions was supported by its diffuse cellular distribution pattern that is distinct from the spindle-like distribution of the majority of tubulins (<xref ref-type="fig" rid="fig5">Figure 5c</xref>).</p>
      </sec>
      <sec>
        <title>Cytokine suppression by GR isoforms</title>
        <p>Additional microarray analyses using cells treated with phorbol 12-myristate 13-acetate (PMA) and ionomycin in the presence or absence of DEX revealed that 38 genes were commonly repressed by the GR-C3 and GR-D3 isoforms (<xref rid="tbl2" ref-type="table">Table 2</xref>). <italic>Interleukin-8</italic> (<italic>IL-8</italic>)<italic>, inducible T-cell costimulator</italic> (<italic>ICOS</italic>)<italic>, colony-stimulating factor 2 (granulocyteâmacrophage)</italic> (<italic>GM-CSF</italic>), and <italic>tumor necrosis factor (ligand) superfamily</italic> (<italic>TNFSF</italic>) <italic>2</italic> (<italic>TNFÎ±</italic>)<italic>, 3, 10, 14</italic>, and <italic>lymphotoxin B</italic> (<italic>LTB</italic>; <xref ref-type="supplementary-material" rid="sup1">Supplementary Figure 2</xref>) belong to this category. In addition, both the GR-C3 and the GR-D3 isoforms induced the anti-inflammatory molecules suppressor of cytokine signaling (SOCS) 1 and 2 (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table 2</xref>), both of which attenuate cytokine signaling in adaptive and innate immunity.<sup><xref ref-type="bibr" rid="bib31">31</xref>, <xref ref-type="bibr" rid="bib32">32</xref></sup> The transforming growth factor b1-stimulated clone 22 domain family member 3 (TSC22D, GILZ), which has been implicated in the immunosuppressive function of glucocorticoids by interfering with NF-<italic>Îº</italic>B-mediated gene transcription in T cells,<sup><xref ref-type="bibr" rid="bib33">33</xref></sup> was also induced by both GR isoforms (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table 2</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary Figure 2</xref>).</p>
      </sec>
      <sec>
        <title>GR translational isoforms are selectively expressed in T cells</title>
        <p>To determine whether GR translational isoforms are expressed in primary CD3+ T cells, we purified the CD3+ T cells (&gt;97%) from peripheral blood samples using magnetic beads. The GR isoforms were examined on freshly isolated cells and cells cultured with the mitogen concanavalin A (ConA). The GR-A and -B isoforms were the predominant isoforms in primary CD3+ T cells, whereas the GR-C and -D isoforms contributed approximately 10â20 and 5% of the total GR protein, respectively (<xref ref-type="fig" rid="fig6">Figure 6a</xref>). Activation by ConA maintained the level of the GR-A/B and -D isoforms and selectively increased the GR-C isoforms. The elevated level of the GR-C isoforms did not enhance the glucocorticoid sensitivity of the ConA-activated cells (<xref ref-type="fig" rid="fig6">Figure 6b</xref>), an observation in line with previous reports indicating that T-cell activation cross-talks with GR signaling.<sup><xref ref-type="bibr" rid="bib34">34</xref></sup> Thus, the glucocorticoid sensitivity of activated T cells is likely a product of T-cell activation and elevated expression of GR-C isoforms. The selective elevation of the GR-C isoforms in activated T cells may have additional impact on T-cell functions. We found that GR-C target genes (<italic>TUBA3E</italic> and <italic>AIM1</italic>) were induced by DEX in ConA-treated T cells, while DEX alone had no effects on the expression of these genes in resting cells (<xref ref-type="fig" rid="fig6">Figure 6c</xref>).</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <sec>
        <title>Selective regulation of genes responsible for cell death by GR translational isoforms</title>
        <p>Using Jurkat cells expressing individual GR translational isoforms, we discovered a novel approach to identify glucocorticoid target genes responsible for cell death. These genes are regulated by the GR-C3, but not by the GR-D3, isoform. GR target genes involved in apoptosis fall into three categories: (1) genes already known to be directly involved in programmed cell death; (2) genes that indirectly contribute to cell death, that is, those involved in cell structural integrity, growth, and metabolism; and (3) genes that have unknown functions in cell death. BIM and MYC belong to the first category, whereas TUBA3E falls into the second, and those in <xref ref-type="supplementary-material" rid="sup1">Supplementary Table 1</xref> belong to the third category. These findings are consistent with the observations made in glucocorticoid-sensitive and -resistant CEM model systems.<sup><xref ref-type="bibr" rid="bib9">9</xref>, <xref ref-type="bibr" rid="bib35">35</xref>, <xref ref-type="bibr" rid="bib36">36</xref>, <xref ref-type="bibr" rid="bib37">37</xref></sup> GR-D3 isoform-expressing cells, even though not sensitive to glucocorticoid killing, are capable of undergoing apoptosis as evidenced after ectopic expression of TUBA3E. Despite the differences in experimental protocols or bioinformatics analysis, current and previous studies using different T-cell apoptosis model systems revealed common GR targets potentially important in glucocorticoid-induced apoptosis. Overall, GR isoforms directly target multiple initiation and execution enzymes for apoptosis as well as apoptosis facilitators such as TUBA3E. It has been demonstrated that microtubules have a key role in BIM translocation to mitochondria and BIM activation.<sup><xref ref-type="bibr" rid="bib38">38</xref>, <xref ref-type="bibr" rid="bib39">39</xref></sup> Our data support that selective isoforms of tubulin, for example, TUBA3E, are involved in this pathway and selective antibodies are needed to further determine the role of TUBA3E. Blockade of some of the GR targets individually only partially blocks glucocorticoid-induced apoptosis. Thus, GR isoform-selective induction of apoptosis in Jurkat cells is likely mediated by multiple factors in concert rather than by the action of a single master gene.</p>
      </sec>
      <sec>
        <title>Cell-specific gene regulation by GR translational isoforms</title>
        <p>It has been reported that the glucocorticoid-induced apoptotic programs have common as well as cell type-specific features. For example, caspase-3, -8, and -9 activities are essential for glucocorticoid-induced apoptosis in murine thymocytes but not in splenic T cells.<sup><xref ref-type="bibr" rid="bib40">40</xref></sup> The GR-C3 isoform is more effective than the other GR isoforms in killing both Jurkat cells and U-2 OS cells. However, few genes selectively regulated by the GR-C3 isoform are common between U-2 OS cells<sup><xref ref-type="bibr" rid="bib12">12</xref></sup> and Jurkat cells. <italic>GZMA</italic> and <italic>MYC</italic> are examples in the small category of common genes. In contrast, the majority of the genes selectively regulated by the GR-C3 isoform are different between the two cell types. Cell-specific gene profiles could be partially due to the difference in the expression level of GR in these two cell types. Expression levels of the GR isoforms in Jurkat cells are at the physiological level, comparable to that of the endogenous GR level in CEM cells, whereas expression levels of the GR isoforms in U-2 OS cells are two times as high as those in Jurkat cells. Cell type-specific actions of glucocorticoids contribute to their anti-inflammatory effects. In addition to killing proinflammatory cells, glucocorticoids protect several other cell types, such as certain epithelia, hepatocytes, ovarian follicular cells, and fibroblasts.<sup><xref ref-type="bibr" rid="bib41">41</xref>, <xref ref-type="bibr" rid="bib42">42</xref></sup> Delineating the role of GR isoforms in these cells will advance our understanding of various actions of glucocorticoids including their benefits as well as side effects, such as osteoporosis, hypothalamic-pituitary-adrenal axis suppression, and metabolic syndrome.</p>
      </sec>
      <sec>
        <title>Gene repression by GR translational isoforms</title>
        <p>We found that the GR-C3 isoform is more efficient in suppressing MYC in Jurkat cells than the GR-D3 isoform. This is consistent with the previous report that the GR-C3 isoform is more efficient than the GR-D3 isoform in repressing antiapoptotic genes, such as <italic>BCL-XL</italic>, <italic>cellular inhibitor of apoptosis protein 1</italic>, and <italic>survivin</italic> in U-2 OS cells.<sup><xref ref-type="bibr" rid="bib43">43</xref></sup> The mechanisms for the GR isoform-selective repression of antiapoptotic genes, however, appeared different in these two model systems. In Jurkat cells, the GR-C3 and -D3 isoforms both bind to the IR-GRE in <italic>MYC</italic> gene, whereas in U-2 OS cells,<sup><xref ref-type="bibr" rid="bib43">43</xref></sup> the GR-C3, but not the GR-D3, isoform was recruited to the promoter regions of the antiapoptotic genes. In Jurkat cells, the acetylation of histone H4 and recruitment of activated RNA polymerase II was repressed by the GR-C3 more than by the GR-D3 isoform. In U-2 OS cells, the DNA-associated GR-C3, but not the GR-D3, isoform inhibits NF-<italic>Îº</italic>B-mediated gene expression.<sup><xref ref-type="bibr" rid="bib43">43</xref></sup> Thus, it seems that cell-specific mechanisms mediate the repression of antiapoptotic genes by the GR translational isoforms. This is consistent with previous reports indicating that all GR isoforms inhibit NF-<italic>Îº</italic>B reporter activity in COS-1 cells<sup><xref ref-type="bibr" rid="bib12">12</xref></sup> and selective GR isoforms inhibit NF-<italic>Îº</italic>B reporter activity in U-2 OS cells.<sup><xref ref-type="bibr" rid="bib43">43</xref></sup></p>
        <p>In addition to the cell specificity, transrepression by GR translational isoforms seems to be gene-specific. In both U-2 OS cells and Jurkat cells, antiapoptotic genes are spared by the GR-D3 isoform. In contrast, proinflammatory cytokines, such as IL-8, GM-CSF, and TNF in both Jurkat cells and U-2 OS cells,<sup><xref ref-type="bibr" rid="bib12">12</xref></sup> are suppressed by all GR isoforms including the GR-D3 isoform. DNA- and ligand-binding domains, critical to transrepression activity, are present in all GR translational isoforms. In addition to transrepression of cytokines, another anti-inflammatory mechanism for both the GR-C and -D isoforms is induction of anti-inflammatory molecules such as SOCS and GILZ. Although apoptosis of proinflammatory T cells contributes to the anti-inflammatory actions of glucocorticoids, killing of immune cells may increase the susceptibility to infection. The ability of the GR-D3 isoform to dissociate cytokine-suppressing and proapoptotic functions of DEX, thus, may be beneficial in inhibiting inflammation and preventing immunosuppression. It will also be interesting to examine the role of GR translational isoforms in other cytokine suppression mechanisms such as RNA turnover.<sup><xref ref-type="bibr" rid="bib44">44</xref></sup></p>
      </sec>
      <sec>
        <title>Cell-specific expression of GR translational isoforms</title>
        <p>It is unclear why glucocorticoid responses among tissues and individuals can be drastically different. Cell-specific expression of glucocorticoid-metabolizing enzymes<sup><xref ref-type="bibr" rid="bib45">45</xref>, <xref ref-type="bibr" rid="bib46">46</xref></sup> and GR coregulators<sup><xref ref-type="bibr" rid="bib47">47</xref>, <xref ref-type="bibr" rid="bib48">48</xref></sup> has been proposed to contribute to the tissue-selective actions of glucocorticoids, although neither mechanism fully explains the tissue specificity of glucocorticoid responses. We propose that GR isoforms have a key role in tissue-specific glucocorticoid responses. Several lines of evidence support this notion. First, GR isoforms have tissue-specific distribution patterns.<sup><xref ref-type="bibr" rid="bib11">11</xref></sup> Second, GR isoforms have unique gene targets.<sup><xref ref-type="bibr" rid="bib11">11</xref>, <xref ref-type="bibr" rid="bib12">12</xref></sup> We found that the GR-C isoforms are selectively upregulated in activated T cells, possibly to counteract the antiapoptotic effects of T-cell activation and maintain glucocorticoid sensitivity.</p>
        <p>Glucocorticoids are essential in treating inflammation and certain cancers, although severe side effects limit their use. Understanding the mechanisms mediating the cell-selective actions of GR isoforms will help us in designing new glucocorticoid drugs with increased efficacy and reduced side effects. GR isoform-selective compounds and drugs that selectively regulate the expression of GR isoforms may provide a new direction for designing glucocorticoids with tissue-selective actions. Our findings support the conclusion that GR isoforms have distinct functions in Jurkat and probably primary T cells.</p>
      </sec>
    </sec>
    <sec sec-type="materials|methods">
      <title>Materials and Methods</title>
      <sec>
        <title>Reagents and antibodies</title>
        <p>DEX was obtained from Steraloids (Newport, RI, USA). Rabbit anti-GR antibodies were from ThermoFisher (Waltham, MA, USA). Rabbit anti-CBP, anti-acetyl histone H4, and mouse antiphosphorylated RNA polymerase II (CTD4H8) antibodies were from Millipore (Billerica, MA, USA). Rabbit anti-MYC antibodies were from Cell Signaling (Danvers, MA, USA). Mouse anti-PARP was from BD Pharmingen (San Diego, CA, USA). Goat anti-rabbit and anti-mouse antibodies conjugated with horseradish peroxidase were from Jackson Immunoresearch (West Grove, PA, USA). Mouse monoclonal anti-FLAG (clone M2, unconjugated and Cy3-conjugated), mouse anti-TUBA (clone B-5-1-2), rabbit anti-RPLP0, rabbit anti-actin, and all other reagents were obtained from Sigma (St. Louis, MO, USA).</p>
      </sec>
      <sec>
        <title>Cell culture</title>
        <p>Jurkat cells (clone E6.1; ATCC, Manassas, VA, USA) and primary T cells were maintained in RPMI medium (Invitrogen, Carlsbad, CA, USA) containing 10% US-defined fetal bovine serum (FBS) (HyClone Laboratories, Logan, UT, USA), 4âmM glutamine, 50âU/ml penicillin, and 50â<italic>Î¼</italic>g/ml streptomycin in a 7% CO<sub>2</sub> atmosphere at 37âÂ°C. Jurkat cell lines stably expressing individual GR isoforms were generated by transfection using Amaxa (Lonza, Walkersville, MD, USA) kits and pTRE-GR plasmids.<sup><xref ref-type="bibr" rid="bib11">11</xref></sup> In all, 500 and 200â<italic>Î¼</italic>g/ml of hygromycin were used for selection and maintenance, respectively, of positive clones. Receptor levels in the stable clones were compared using western blot analysis. FLAG-TUBA3E, pSingle-TUBA3Esi, pcDNA3-cmyc, and pRetrosuper-Myc shRNA were transfected into Jurkat cells using Amaxa and selected using geneticin or puromycin. Human CD3+ cells were purified from peripheral blood mononuclear cells (American Red Cross, St. Paul, MN, USA) using Miltenyi Biotec (Auburn, CA, USA) kits. Cells were cultured in growth media supplemented with 10% charcoal-dextran-stripped FBS to remove endogenous glucocorticoids for 2 days before experiments.</p>
      </sec>
      <sec>
        <title>DNA plasmids</title>
        <p>GR isoform-expressing pTRE plasmids were described previously.<sup><xref ref-type="bibr" rid="bib11">11</xref>, <xref ref-type="bibr" rid="bib12">12</xref></sup> pcDNA3-cmyc (Addgene plasmid 16011)<sup><xref ref-type="bibr" rid="bib49">49</xref></sup> and pRetrosuper-Myc shRNA (Addgene plasmid 15662)<sup><xref ref-type="bibr" rid="bib50">50</xref></sup> were described previously. pCDNA-TUBA3E was made by subcloning TUBA3E into pCDNA3.0 (Invitrogen, Carlsbad, CA, USA). pSingle (Clontech, Mountain View, CA, USA)-TUBA3Esi contains TUBA3E shRNA targeting the sequence 5â²-CGGTTGAGGTCTGGAAGTA-3â². Cloned sequences were verified at the Genomics core facility at Northwestern University.</p>
      </sec>
      <sec>
        <title>Western blot analysis</title>
        <p>Procedures for preparing cell lysates for western blot analysis were described previously.<sup><xref ref-type="bibr" rid="bib11">11</xref></sup> Lysates containing 10â50â<italic>Î¼</italic>g of proteins were resolved on 4â12% NuPage bisâtris gels (Invitrogen) and titers for antibodies were: anti-GR antibodies (1â:â500), anti-BIM (1â:â1000), anti-MYC (1â:â5000), anti-FLAG (1â:â5000), anti-RPLP0 (1â:â2000), anti-PARP (1â:â1000), anti-TUBA (1â:â300â000), and anti-actin (1â:â100â000). Secondary antibodies were used at 1â:â10â000 dilution for 30âmin. The membranes were probed with ECL detection reagent (GE Amersham, Pittsburgh, PA, USA) and exposed to ECL Hyperfilm (GE Amersham).</p>
      </sec>
      <sec>
        <title>Immunofluorescent staining</title>
        <p>Jurkat cells expressing the GR-C3 isoform and FLAG-TUBA3E were treated with vehicle or DEX (10ânM, 20âh), transferred onto slides via cytospin, and fixed with 4% paraformaldehyde. To stain FLAG-TUBA3E, slides were blocked with 0.5% blocking reagent (Perkin-Elmer, Waltham, MA, USA) in PBS containing 0.1% Triton X-100 for 30âmin and incubated with 1â:â100 Cy3-conjugated mouse anti-FLAG for 2âh. To stain tubulin, slides were blocked with 10% normal goat serum before incubating with 1â:â100 mouse anti-TUBA overnight. After blocking, slides were incubated with 1â:â200 dilution of Dylight488 anti-mouse antibodies (Vector Laboratories, Burlingame, CA, USA) in 5% normal human serum (Jackson ImmunoReseach). Slides were then incubated with 1â<italic>Î¼</italic>g/ml of DAPI and mounted with Floromount. Images were obtained on a Nikon C1Si confocal inverted microscope. Dylight488 was imaged using the 488ânm excitation line of an argon laser and an emission bandpass filter of 518ânm. DAPI was excited with the 402ânm argon UV laser and imaged through a 461ânm bandpass filter. Cy3 was imaged using the 561ânm excitation line of an argon laser and an emission bandpass filter of 570ânm. A Ã 60 NA 1.25 PlanApochromat objective was used for all images.</p>
      </sec>
      <sec>
        <title>Microarray</title>
        <p>Approximately 10 million cells expressing the GR-C3 or GR-D3 isoforms were treated with vehicle, DEX (100ânM, 6âh), PMA (10âng/ml)+ionomycin (50â<italic>Î¼</italic>M) for 5âh, or DEX for 1âh followed by PMA+ionomycin+DEX for an additional 5âh. Total RNA was harvested and treated with DNaseI using Stratagene Absolute RNA kits (Stratagene, San Diego, CA, USA) according to the manufacturer's protocol. Biotin-labeled cRNA was generated using the Illumina TotalPrep RNA Amplification kit (Ambion, Foster City, CA, USA). Briefly, 250âng of total RNA with 260/280 absorbance ratio of 1.8â2.0 and RNA integrity number of more than 9 were reverse transcribed with oligo (dT) primer bearing T7 promoter. The first-strand cDNAs were used to make the second strand. Purified second-strand cDNA along with biotin UTPs were used to generate biotinylated antisense RNA of each mRNA in an <italic>in vitro</italic> transcription reaction. Size distribution profiles for the labeled cRNA samples were evaluated on a bioanalyzer. After purification, labeled cRNA (1.5â<italic>Î¼</italic>g) from each sample was hybridized with HumanRef-8 expression Beadchips (Illumina, San Diego, CA, USA) at 55âÂ°C overnight. After washing, signals were developed with streptavidin-Cy3 and the chip was scanned with an Illumina BeadArray Reader. EachRef-8 Beadchip can profile eight samples on a single slide in parallel, and therefore samples from three biological replicates were randomly assigned onto different slides. Two MicroArray quality control (MAQC) RNA samples (Stratagene Universal RNA and Ambion Brain RNA) were added on each slide for normalization. Thus, a total of 32 arrays (2 cell lines Ã 4 treatments Ã 3 biological replicates+8 MAQC samples) were performed. Raw signal intensities of each probe were obtained using data analysis software (Beadstudio; Illumina) and imported to the Lumi package of Bioconductor for data transformation and normalization.<sup><xref ref-type="bibr" rid="bib51">51</xref>, <xref ref-type="bibr" rid="bib52">52</xref></sup> A/P call detection was performed based on detection <italic>P</italic>-value. A total of 16â961 out of 45â281 probes with &lt;0.01 in at least one sample were considered as valid signals. Differentially expressed genes were identified using an analysis of variance (ANOVA) model with empirical Bayesian variance estimation. The problem of multiple comparisons was corrected using the false discovery rate (FDR). Genes were identified as being differentially expressed when having a statistically significant change (up or down) in expression levels in different treatment groups (raw <italic>P</italic>-value &lt;0.01, FDR &lt;0.05, and change &gt;1.5-fold).</p>
      </sec>
      <sec>
        <title>Real-time RT-PCR</title>
        <p>RNA samples were extracted as above. The level of individual mRNA in each sample was measured using the predesigned expression assays and one-step RT-PCR procedure on a Prism 7500HT thermocycler (Applied Biosystems, Foster City, CA, USA) as described previously.<sup><xref ref-type="bibr" rid="bib11">11</xref></sup> Each experiment was performed in duplicate at least two times. Quantification was achieved using the Sequence Detection Software 2.0 Absolute Level subroutine (Applied Biosystems). Human RPLP0 mRNA levels were measured using primers 5â²-TGCAGCTGATCAAGACTGGAGACA-3â² and 5â²-TCCAGGAAGCGAGAATGCAGAGTT-3â² and the probe 5â²-AAGCCACGCTGCTGAACATGCTCAACAT-3â² labeled with FAM reporter at the 5â² end and Iowa Black quencher at the 3â² end. RPLP0 mRNA levels were used to normalize the levels of genes of interests. For miRNA and small nucleolar RNA measurement, total RNAs were isolated using MirVana kits (Ambion). Taqman kits specific to let-7a, miR-15b, miR-17, miR-195, and RNU48 (Applied Biosystems) were used for RT reaction and amplification. The level of miRNAs was normalized to that of RNU48.</p>
      </sec>
      <sec>
        <title>ChIP assays</title>
        <p>ChIP assays were performed using ChIP assay kits from Millipore according to the manufacturer's protocol and have been described previously.<sup><xref ref-type="bibr" rid="bib12">12</xref></sup> Briefly, 5 Ã 10<sup>6</sup> cells were cultured in steroid-free medium for 48âh and then were treated with vehicle or DEX (100ânM) for 3âh. The amount of total input DNA for each immunoprecipitation reaction was 140â<italic>Î¼</italic>g. The amount of antibodies (in <italic>Î¼</italic>l) per immunoprecipitation reaction was 5 for anti-GR, 4 for anti-Pol II, and 0.5 for anti-acetylated H4. The level of precipitated DNA containing a 109âbp fragment in the first intron of <italic>MYC</italic> gene was quantified using real-time PCR analysis as described previously.<sup><xref ref-type="bibr" rid="bib12">12</xref></sup> Each experiment was performed in duplicate at least two times. Quantification was achieved using the Sequence Detection Software 2.0 Absolute Level subroutine (Applied Biosystems). The primer sequences were 5â²-TTGCATCCTGAGCTCCTTGGAGTA-3â² and 5â²-AGCCGAAATTTAAATGCCCTCCCG-3â². The probe (FAM labeled) sequence was 5â²-ATATCGCCTGTGTGAGCCAGATCGCT-3â². All measurements were normalized to the level of input DNA.</p>
      </sec>
      <sec>
        <title>Flow cytometry analysis</title>
        <p>Annexin-V and propidium iodide (PI) labeling was processed using the Annexin-V-FITC apoptosis detection kit (Biovision, Mountain View, CA, USA) according to the manufacturer's instructions. A total of 1.5 Ã 10<sup>5</sup> control or treated cells were processed and 1 Ã 10<sup>4</sup> cells were analyzed using a BD LSRII flow cytometer (Franklin Lakes, NJ, USA) with an excitation of 488ânm and emission at 530ânm (for Annexin-V-FITC) or 585ânm (for PI).</p>
      </sec>
      <sec>
        <title>Statistical analysis</title>
        <p>For comparison of two groups, Student's <italic>t</italic>-test was performed. For comparison of three or more treatment groups, one-way ANOVA was performed followed by Tukey's <italic>post hoc</italic> comparison using Prism software (GraphPad, San Diego, CA, USA). A <italic>P</italic>-value&lt;0.05 was considered significant.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <p>We thank Dr. Navdeep Chandel for a critical review of the manuscript. This work was supported by the NIH Grants, NIH 1R01HL094558-01A1 (NZL), NIH 3R01HL094558-01A1S1 (NZL), and NIH 2R37HL068546-26 (RPS).</p>
    </ack>
    <glossary>
      <def-list>
        <def-item>
          <term>ANOVA</term>
          <def>
            <p>analysis of variance</p>
          </def>
        </def-item>
        <def-item>
          <term>AKAP13</term>
          <def>
            <p>A kinase anchor protein 13</p>
          </def>
        </def-item>
        <def-item>
          <term>TUBA</term>
          <def>
            <p><italic>Î±</italic>-tubulin</p>
          </def>
        </def-item>
        <def-item>
          <term>ALL</term>
          <def>
            <p>acute lymphoblastic leukemia</p>
          </def>
        </def-item>
        <def-item>
          <term>ATG12</term>
          <def>
            <p>autophagy-related 12 homolog (<italic>Saccharomyces cerevisiae</italic>)</p>
          </def>
        </def-item>
        <def-item>
          <term>BCL-2</term>
          <def>
            <p>B-cell CLL/lymphoma 2</p>
          </def>
        </def-item>
        <def-item>
          <term>BAD</term>
          <def>
            <p>BCL-2-associated agonist of cell death</p>
          </def>
        </def-item>
        <def-item>
          <term>BAX</term>
          <def>
            <p>BCL-2-associated X protein</p>
          </def>
        </def-item>
        <def-item>
          <term>BBC3, PUMA</term>
          <def>
            <p>BCL-2-binding component 3</p>
          </def>
        </def-item>
        <def-item>
          <term>BIM, BCL2L11</term>
          <def>
            <p>BCL-2-interacting mediator of cell death</p>
          </def>
        </def-item>
        <def-item>
          <term>ChIP</term>
          <def>
            <p>chromatin immunoprecipitation</p>
          </def>
        </def-item>
        <def-item>
          <term>GM-CSF</term>
          <def>
            <p>colony-stimulating factor 2 (granulocyteâmacrophage)</p>
          </def>
        </def-item>
        <def-item>
          <term>CDKN2D or p19</term>
          <def>
            <p>cyclin-dependent kinase inhibitor 2D</p>
          </def>
        </def-item>
        <def-item>
          <term>DAPL1</term>
          <def>
            <p>death-associated protein-like 1</p>
          </def>
        </def-item>
        <def-item>
          <term>DEX</term>
          <def>
            <p>dexamethasone</p>
          </def>
        </def-item>
        <def-item>
          <term>FDR</term>
          <def>
            <p>false discovery rate</p>
          </def>
        </def-item>
        <def-item>
          <term>FBS</term>
          <def>
            <p>fetal bovine serum</p>
          </def>
        </def-item>
        <def-item>
          <term>GR</term>
          <def>
            <p>glucocorticoid receptor</p>
          </def>
        </def-item>
        <def-item>
          <term>GZMA</term>
          <def>
            <p>granzyme A</p>
          </def>
        </def-item>
        <def-item>
          <term>ICOS</term>
          <def>
            <p>inducible T-cell costimulator</p>
          </def>
        </def-item>
        <def-item>
          <term>ING1</term>
          <def>
            <p>inhibitor of growth family, member 1</p>
          </def>
        </def-item>
        <def-item>
          <term>ITPR1</term>
          <def>
            <p>inositol 1,4,5-triphosphate receptor, type 1</p>
          </def>
        </def-item>
        <def-item>
          <term>IL-8</term>
          <def>
            <p>interleukin-8</p>
          </def>
        </def-item>
        <def-item>
          <term>IR-GRE</term>
          <def>
            <p>inverse repeat negative glucocorticoid response elements</p>
          </def>
        </def-item>
        <def-item>
          <term>LTB</term>
          <def>
            <p>lymphotoxin B</p>
          </def>
        </def-item>
        <def-item>
          <term>MAQC</term>
          <def>
            <p>microarray quality control</p>
          </def>
        </def-item>
        <def-item>
          <term>miRNAs</term>
          <def>
            <p>microRNAs</p>
          </def>
        </def-item>
        <def-item>
          <term>PMA</term>
          <def>
            <p>phorbol 12-myristate 13-acetate</p>
          </def>
        </def-item>
        <def-item>
          <term>PIM3</term>
          <def>
            <p>pim-3 oncogene</p>
          </def>
        </def-item>
        <def-item>
          <term>PARP</term>
          <def>
            <p>poly-ADP-ribose polymerase</p>
          </def>
        </def-item>
        <def-item>
          <term>SATB1</term>
          <def>
            <p>SATB homeobox 1</p>
          </def>
        </def-item>
        <def-item>
          <term>SOCS</term>
          <def>
            <p>suppressor of cytokine signaling</p>
          </def>
        </def-item>
        <def-item>
          <term>TSC22D, GILZ</term>
          <def>
            <p>transforming growth factor b1-stimulated clone 22 domain family member 3</p>
          </def>
        </def-item>
        <def-item>
          <term>TNFRSF21, TNF-related death receptor-6</term>
          <def>
            <p>tumor necrosis factor receptor superfamily, member 21</p>
          </def>
        </def-item>
        <def-item>
          <term>TNFSF</term>
          <def>
            <p>tumor necrosis factor (ligand) superfamily 2 (TNF<italic>Î±</italic>)</p>
          </def>
        </def-item>
        <def-item>
          <term>MYC</term>
          <def>
            <p>v-myc myelocytomatosis viral oncogene homolog (avian)</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p><xref ref-type="supplementary-material" rid="sup1">Supplementary Information</xref> accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)</p>
      </fn>
      <fn>
        <p>Edited by A Stephanou</p>
      </fn>
    </fn-group>
    <notes>
      <p>The authors declare no conflict of interest.</p>
    </notes>
    <ref-list>
      <ref id="bib1">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rhen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Cidlowski</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Antiinflammatory action of glucocorticoids â new mechanisms for old drugs</article-title>
          <source>N Engl J Med</source>
          <year>2005</year>
          <volume>353</volume>
          <fpage>1711</fpage>
          <lpage>1723</lpage>
          <pub-id pub-id-type="pmid">16236742</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib2">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mok</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Gil-Gomez</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Coles</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Taga</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tolaini</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Bad can act as a key regulator of T cell apoptosis and T cell development</article-title>
          <source>J Exp Med</source>
          <year>1999</year>
          <volume>189</volume>
          <fpage>575</fpage>
          <lpage>586</lpage>
          <pub-id pub-id-type="pmid">9927519</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib3">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Malone</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>McColl</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Distelhorst</surname>
              <given-names>CW</given-names>
            </name>
          </person-group>
          <article-title>Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple models of glucocorticoid-induced apoptosis</article-title>
          <source>J Biol Chem</source>
          <year>2003</year>
          <volume>278</volume>
          <fpage>23â861</fpage>
          <lpage>23â867</lpage>
        </mixed-citation>
      </ref>
      <ref id="bib4">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hoijman</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rocha Viegas</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Keller Sarmiento</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Rosenstein</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Pecci</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Involvement of Bax protein in the prevention of glucocorticoid-induced thymocytes apoptosis by melatonin</article-title>
          <source>Endocrinology</source>
          <year>2004</year>
          <volume>145</volume>
          <fpage>418</fpage>
          <lpage>425</lpage>
          <pub-id pub-id-type="pmid">14500572</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib5">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Broome</surname>
              <given-names>HE</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Diccianni</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Camitta</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Monia</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Dean</surname>
              <given-names>NM</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of Bcl-xL expression sensitizes T-cell acute lymphoblastic leukemia cells to chemotherapeutic drugs</article-title>
          <source>Leuk Res</source>
          <year>2002</year>
          <volume>26</volume>
          <fpage>311</fpage>
          <lpage>316</lpage>
          <pub-id pub-id-type="pmid">11792421</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib6">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rogatsky</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Hittelman</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Pearce</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Garabedian</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Distinct glucocorticoid receptor transcriptional regulatory surfaces mediate the cytotoxic and cytostatic effects of glucocorticoids</article-title>
          <source>Mol Cell Biol</source>
          <year>1999</year>
          <volume>19</volume>
          <fpage>5036</fpage>
          <lpage>5049</lpage>
          <pub-id pub-id-type="pmid">10373553</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib7">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Herr</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Gassler</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Friess</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Buchler</surname>
              <given-names>MW</given-names>
            </name>
          </person-group>
          <article-title>Regulation of differential pro- and anti-apoptotic signaling by glucocorticoids</article-title>
          <source>Apoptosis</source>
          <year>2007</year>
          <volume>12</volume>
          <fpage>271</fpage>
          <lpage>291</lpage>
          <pub-id pub-id-type="pmid">17191112</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib8">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ploner</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Presul</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Renner</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Schrocksnadel</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Rainer</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia</article-title>
          <source>J Steroid Biochem Mol Biol</source>
          <year>2005</year>
          <volume>93</volume>
          <fpage>153</fpage>
          <lpage>160</lpage>
          <pub-id pub-id-type="pmid">15860257</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib9">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miller</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Komak</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Webb</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Leiter</surname>
              <given-names>EH</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>EB</given-names>
            </name>
          </person-group>
          <article-title>Gene expression profiling of leukemic cells and primary thymocytes predicts a signature for apoptotic sensitivity to glucocorticoids</article-title>
          <source>Cancer Cell Int</source>
          <year>2007</year>
          <volume>7</volume>
          <fpage>18</fpage>
          <pub-id pub-id-type="pmid">18045478</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib10">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oakley</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Webster</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Sar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>JrCR</given-names>
            </name>
            <name>
              <surname>Cidlowski</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Expression and subcellular distribution of the beta-isoform of the human glucocorticoid receptor</article-title>
          <source>Endocrinology</source>
          <year>1997</year>
          <volume>138</volume>
          <fpage>5028</fpage>
          <lpage>5038</lpage>
          <pub-id pub-id-type="pmid">9348235</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib11">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>NZ</given-names>
            </name>
            <name>
              <surname>Cidlowski</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes</article-title>
          <source>Mol Cell</source>
          <year>2005</year>
          <volume>18</volume>
          <fpage>331</fpage>
          <lpage>342</lpage>
          <pub-id pub-id-type="pmid">15866175</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib12">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>NZ</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Grissom</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Cidlowski</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor</article-title>
          <source>Mol Cell Biol</source>
          <year>2007</year>
          <volume>27</volume>
          <fpage>7143</fpage>
          <lpage>7160</lpage>
          <pub-id pub-id-type="pmid">17682054</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib13">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Riml</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ausserlechner</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Geley</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kofler</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Glucocorticoid receptor heterozygosity combined with lack of receptor auto-induction causes glucocorticoid resistance in Jurkat acute lymphoblastic leukemia cells</article-title>
          <source>Cell Death Differ</source>
          <year>2004</year>
          <volume>11</volume>
          <supplement>(Suppl 1</supplement>
          <fpage>S65</fpage>
          <lpage>S72</lpage>
          <pub-id pub-id-type="pmid">15017388</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib14">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buckley</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Kuo</surname>
              <given-names>CT</given-names>
            </name>
            <name>
              <surname>Leiden</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc â dependent pathway</article-title>
          <source>Nat Immunol</source>
          <year>2001</year>
          <volume>2</volume>
          <fpage>698</fpage>
          <lpage>704</lpage>
          <pub-id pub-id-type="pmid">11477405</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib15">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thulasi</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Harbour</surname>
              <given-names>DV</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>EB</given-names>
            </name>
          </person-group>
          <article-title>Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis</article-title>
          <source>J Biol Chem</source>
          <year>1993</year>
          <volume>268</volume>
          <fpage>18â306</fpage>
          <lpage>18â312</lpage>
        </mixed-citation>
      </ref>
      <ref id="bib16">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Medh</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>EB</given-names>
            </name>
          </person-group>
          <article-title>Glucocorticoid mediated transcriptional repression of c-myc in apoptotic human leukemic CEM cells</article-title>
          <source>J Steroid Biochem Mol Biol</source>
          <year>2000</year>
          <volume>73</volume>
          <fpage>195</fpage>
          <lpage>202</lpage>
          <pub-id pub-id-type="pmid">11070348</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib17">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Surjit</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ganti</surname>
              <given-names>KP</given-names>
            </name>
            <name>
              <surname>Mukherji</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hua</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Metzger</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Widespread negative response elements mediate direct repression by agonist- liganded glucocorticoid receptor</article-title>
          <source>Cell</source>
          <year>2011</year>
          <volume>145</volume>
          <fpage>224</fpage>
          <lpage>241</lpage>
          <pub-id pub-id-type="pmid">21496643</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib18">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Rafiuddin-Shah</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tu</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Jeffers</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Zambetti</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Hsieh</surname>
              <given-names>JJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies</article-title>
          <source>Nat Cell Biol</source>
          <year>2006</year>
          <volume>8</volume>
          <fpage>1348</fpage>
          <lpage>1358</lpage>
          <pub-id pub-id-type="pmid">17115033</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib19">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Willis</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Kaufmann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>van Delft</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Czabotar</surname>
              <given-names>PE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak</article-title>
          <source>Science</source>
          <year>2007</year>
          <volume>315</volume>
          <fpage>856</fpage>
          <lpage>859</lpage>
          <pub-id pub-id-type="pmid">17289999</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib20">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bouillet</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Metcalf</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Tarlinton</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Kay</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Kontgen</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity</article-title>
          <source>Science</source>
          <year>1999</year>
          <volume>286</volume>
          <fpage>1735</fpage>
          <lpage>1738</lpage>
          <pub-id pub-id-type="pmid">10576740</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib21">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abrams</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Robertson</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Yoon</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wickstrom</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of glucocorticoid-induced apoptosis by targeting the major splice variants of BIM mRNA with small interfering RNA and short hairpin RNA</article-title>
          <source>J Biol Chem</source>
          <year>2004</year>
          <volume>279</volume>
          <fpage>55â809</fpage>
          <lpage>55â817</lpage>
        </mixed-citation>
      </ref>
      <ref id="bib22">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Quearry</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Harada</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>p38-MAP kinase activation followed by BIM induction is essential for glucocorticoid-induced apoptosis in lymphoblastic leukemia cells</article-title>
          <source>FEBS Lett</source>
          <year>2006</year>
          <volume>580</volume>
          <fpage>3539</fpage>
          <lpage>3544</lpage>
          <pub-id pub-id-type="pmid">16730715</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib23">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ploner</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rainer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Niederegger</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Eduardoff</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Villunger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Geley</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia</article-title>
          <source>Leukemia</source>
          <year>2008</year>
          <volume>22</volume>
          <fpage>370</fpage>
          <lpage>377</lpage>
          <pub-id pub-id-type="pmid">18046449</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib24">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Linsley</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Schelter</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Burchard</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kibukawa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Bartz</surname>
              <given-names>SR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression</article-title>
          <source>Mol Cell Biol</source>
          <year>2007</year>
          <volume>27</volume>
          <fpage>2240</fpage>
          <lpage>2252</lpage>
          <pub-id pub-id-type="pmid">17242205</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib25">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cimmino</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Calin</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Fabbri</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Iorio</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Ferracin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shimizu</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>miR-15 and miR-16 induce apoptosis by targeting BCL2</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2005</year>
          <volume>102</volume>
          <fpage>13944</fpage>
          <lpage>13949</lpage>
          <pub-id pub-id-type="pmid">16166262</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib26">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rainer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ploner</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jesacher</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ploner</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Eduardoff</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mansha</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia</article-title>
          <source>Leukemia</source>
          <year>2009</year>
          <volume>23</volume>
          <fpage>746</fpage>
          <lpage>752</lpage>
          <pub-id pub-id-type="pmid">19148136</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib27">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>LK</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Cidlowski</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Glucocorticoids modulate microRNA expression and processing during lymphocyte apoptosis</article-title>
          <source>J Biol Chem</source>
          <year>2010</year>
          <volume>285</volume>
          <fpage>36â698</fpage>
          <lpage>36â708</lpage>
        </mixed-citation>
      </ref>
      <ref id="bib28">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamaguchi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bhalla</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>HG</given-names>
            </name>
          </person-group>
          <article-title>Regulation of Bax activation and apoptotic response to microtubule-damaging agents by p53 transcription-dependent and -independent pathways</article-title>
          <source>J Biol Chem</source>
          <year>2004</year>
          <volume>279</volume>
          <fpage>39â431</fpage>
          <lpage>39â437</lpage>
        </mixed-citation>
      </ref>
      <ref id="bib29">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tudor</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Aguilera</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Halverson</surname>
              <given-names>DO</given-names>
            </name>
            <name>
              <surname>Laing</surname>
              <given-names>ND</given-names>
            </name>
            <name>
              <surname>Sausville</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title>Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-xL protein levels</article-title>
          <source>Cell Death Differ</source>
          <year>2000</year>
          <volume>7</volume>
          <fpage>574</fpage>
          <lpage>586</lpage>
          <pub-id pub-id-type="pmid">10822281</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib30">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Makin</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Corfe</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Griffiths</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Thistlethwaite</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hickman</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Dive</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Damage-induced Bax N-terminal change, translocation to mitochondria and formation of Bax dimers/complexes occur regardless of cell fate</article-title>
          <source>EMBO J</source>
          <year>2001</year>
          <volume>20</volume>
          <fpage>6306</fpage>
          <lpage>6315</lpage>
          <pub-id pub-id-type="pmid">11707402</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib31">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marine</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Topham</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>McKay</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Parganas</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Stravopodis</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality</article-title>
          <source>Cell</source>
          <year>1999</year>
          <volume>98</volume>
          <fpage>609</fpage>
          <lpage>616</lpage>
          <pub-id pub-id-type="pmid">10490100</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib32">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Metcalf</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Greenhalgh</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Viney</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Willson</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Starr</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Nicola</surname>
              <given-names>NA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gigantism in mice lacking suppressor of cytokine signalling-2</article-title>
          <source>Nature</source>
          <year>2000</year>
          <volume>405</volume>
          <fpage>1069</fpage>
          <lpage>1073</lpage>
          <pub-id pub-id-type="pmid">10890450</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib33">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ayroldi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Migliorati</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bruscoli</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Marchetti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Zollo</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Cannarile</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB</article-title>
          <source>Blood</source>
          <year>2001</year>
          <volume>98</volume>
          <fpage>743</fpage>
          <lpage>753</lpage>
          <pub-id pub-id-type="pmid">11468175</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib34">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jamieson</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>KR</given-names>
            </name>
          </person-group>
          <article-title>Crosstalk pathway for inhibition of glucocorticoid-induced apoptosis by T cell receptor signaling</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2000</year>
          <volume>97</volume>
          <fpage>7319</fpage>
          <lpage>7324</lpage>
          <pub-id pub-id-type="pmid">10860997</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib35">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Obexer</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Certa</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Kofler</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Helmberg</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Expression profiling of glucocorticoid-treated T-ALL cell lines: rapid repression of multiple genes involved in RNA-, protein- and nucleotide synthesis</article-title>
          <source>Oncogene</source>
          <year>2001</year>
          <volume>20</volume>
          <fpage>4324</fpage>
          <lpage>4336</lpage>
          <pub-id pub-id-type="pmid">11466613</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib36">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rainer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Riml</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ploner</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jesacher</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Achmuller</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia</article-title>
          <source>Blood</source>
          <year>2006</year>
          <volume>107</volume>
          <fpage>2061</fpage>
          <lpage>2069</lpage>
          <pub-id pub-id-type="pmid">16293608</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib37">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tissing</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>den Boer</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Meijerink</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Menezes</surname>
              <given-names>RX</given-names>
            </name>
            <name>
              <surname>Swagemakers</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>van der Spek</surname>
              <given-names>PJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells</article-title>
          <source>Blood</source>
          <year>2007</year>
          <volume>109</volume>
          <fpage>3929</fpage>
          <lpage>3935</lpage>
          <pub-id pub-id-type="pmid">17218380</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib38">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Moudgil</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ross</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>HM</given-names>
            </name>
          </person-group>
          <article-title>Apoptosis of non-small-cell lung cancer cell lines after paclitaxel treatment involves the BH3-only proapoptotic protein Bim</article-title>
          <source>Cell Death Differ</source>
          <year>2005</year>
          <volume>12</volume>
          <fpage>292</fpage>
          <lpage>303</lpage>
          <pub-id pub-id-type="pmid">15711598</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib39">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Puthalakath</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>O'Reilly</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Strasser</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex</article-title>
          <source>Mol Cell</source>
          <year>1999</year>
          <volume>3</volume>
          <fpage>287</fpage>
          <lpage>296</lpage>
          <pub-id pub-id-type="pmid">10198631</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib40">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>McPherson</surname>
              <given-names>KG</given-names>
            </name>
            <name>
              <surname>Reichardt</surname>
              <given-names>HM</given-names>
            </name>
          </person-group>
          <article-title>Glucocorticoids engage different signal transduction pathways to induce apoptosis in thymocytes and mature T cells</article-title>
          <source>J Immunol</source>
          <year>2006</year>
          <volume>176</volume>
          <fpage>1695</fpage>
          <lpage>1702</lpage>
          <pub-id pub-id-type="pmid">16424199</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib41">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amsterdam</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sasson</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The anti-inflammatory action of glucocorticoids is mediated by cell type specific regulation of apoptosis</article-title>
          <source>Mol Cell Endocrinol</source>
          <year>2002</year>
          <volume>189</volume>
          <fpage>1</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">12039060</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib42">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Viegas</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Hoijman</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Beato</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pecci</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms involved in tissue-specific apopotosis regulated by glucocorticoids</article-title>
          <source>J Steroid Biochem Mol Biol</source>
          <year>2008</year>
          <volume>109</volume>
          <fpage>273</fpage>
          <lpage>278</lpage>
          <pub-id pub-id-type="pmid">18424036</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib43">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gross</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Oakley</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Scoltock</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Jewell</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Cidlowski</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Glucocorticoid receptor alpha isoform-selective regulation of antiapoptotic genes in osteosarcoma cells: a new mechanism for glucocorticoid resistance</article-title>
          <source>Mol Endocrinol</source>
          <year>2011</year>
          <volume>25</volume>
          <fpage>1087</fpage>
          <lpage>1099</lpage>
          <pub-id pub-id-type="pmid">21527497</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib44">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ishmael</surname>
              <given-names>FT</given-names>
            </name>
            <name>
              <surname>Fang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Houser</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Pearce</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Abdelmohsen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Zhan</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The human glucocorticoid receptor as an RNA-binding protein: global analysis of glucocorticoid receptor-associated transcripts and identification of a target RNA motif</article-title>
          <source>J Immunol</source>
          <year>2011</year>
          <volume>186</volume>
          <fpage>1189</fpage>
          <lpage>1198</lpage>
          <pub-id pub-id-type="pmid">21148795</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib45">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Funder</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Pearce</surname>
              <given-names>PT</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>AI</given-names>
            </name>
          </person-group>
          <article-title>Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated</article-title>
          <source>Science</source>
          <year>1988</year>
          <volume>242</volume>
          <fpage>583</fpage>
          <lpage>585</lpage>
          <pub-id pub-id-type="pmid">2845584</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib46">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Albiston</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Obeyesekere</surname>
              <given-names>VR</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Krozowski</surname>
              <given-names>ZS</given-names>
            </name>
          </person-group>
          <article-title>Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme</article-title>
          <source>Mol Cell Endocrinol</source>
          <year>1994</year>
          <volume>105</volume>
          <fpage>R11</fpage>
          <lpage>R17</lpage>
          <pub-id pub-id-type="pmid">7859916</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib47">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jenkins</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Pullen</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Darimont</surname>
              <given-names>BD</given-names>
            </name>
          </person-group>
          <article-title>Novel glucocorticoid receptor coactivator effector mechanisms</article-title>
          <source>Trends Endocrinol Metab</source>
          <year>2001</year>
          <volume>12</volume>
          <fpage>122</fpage>
          <lpage>126</lpage>
          <pub-id pub-id-type="pmid">11306337</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib48">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Q</given-names>
            </name>
          </person-group>
          <article-title>Review of the <italic>in vivo</italic> functions of the p160 steroid receptor coactivator family</article-title>
          <source>Mol Endocrinol</source>
          <year>2003</year>
          <volume>17</volume>
          <fpage>1681</fpage>
          <lpage>1692</lpage>
          <pub-id pub-id-type="pmid">12805412</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib49">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ricci</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Dews</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Thomas-Tikhonenko</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dicker</surname>
              <given-names>DT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity</article-title>
          <source>Mol Cell Biol</source>
          <year>2004</year>
          <volume>24</volume>
          <fpage>8541</fpage>
          <lpage>8555</lpage>
          <pub-id pub-id-type="pmid">15367674</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib50">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Popov</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wanzel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Madiredjo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Beijersbergen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bernards</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The ubiquitin-specific protease USP28 is required for MYC stability</article-title>
          <source>Nat Cell Biol</source>
          <year>2007</year>
          <volume>9</volume>
          <fpage>765</fpage>
          <lpage>774</lpage>
          <pub-id pub-id-type="pmid">17558397</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib51">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Du</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kibbe</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Lumi: a pipeline for processing Illumina microarray</article-title>
          <source>Bioinformatics</source>
          <year>2008</year>
          <volume>24</volume>
          <fpage>1547</fpage>
          <lpage>1548</lpage>
          <pub-id pub-id-type="pmid">18467348</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib52">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Huber</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Kibbe</surname>
              <given-names>WA</given-names>
            </name>
          </person-group>
          <article-title>Model-based variance-stabilizing transformation for Illumina microarray data</article-title>
          <source>Nucleic Acids Res</source>
          <year>2008</year>
          <volume>36</volume>
          <fpage>e11</fpage>
          <pub-id pub-id-type="pmid">18178591</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
    <sec sec-type="supplementary-material" id="sup1">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="xob1">
        <label>Supplementary Figure 1</label>
        <media mimetype="image" mime-subtype="tiff" xlink:href="cddis2012193x1.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="xob2">
        <label>Supplementary Figure 2</label>
        <media mimetype="image" mime-subtype="tiff" xlink:href="cddis2012193x2.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="xob3">
        <label>Supplementary Table 1</label>
        <media mimetype="application" mime-subtype="pdf" xlink:href="cddis2012193x3.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="xob4">
        <label>Supplementary Table 2</label>
        <media mimetype="application" mime-subtype="pdf" xlink:href="cddis2012193x4.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </back>
  <floats-group>
    <fig id="fig1">
      <label>Figure 1</label>
      <caption>
        <p>GR isoforms mediate Jurkat cell apoptosis selectively. (<bold>a</bold>) Individual GR isoforms were expressed stably in Jurkat cells. Expression level of GR isoforms in each clone is similar as indicated by western blot analysis. Vehicle- or DEX- (100ânM, 48âh) treated cells were examined on parameters including PI staining (<bold>b</bold>), Annexin-V staining (<bold>c</bold>), DNA degradation (<bold>d</bold>), and the level of cleaved PARP (<bold>e</bold>). Averages (Â±S.E.M.) of at least three experiments are shown in the bar graphs. *Significantly greater than GR<italic>Î±</italic>; **significantly less than GR<italic>Î±</italic>, <italic>P</italic>&lt;0.05, ANOVA followed by Tukey's <italic>post hoc</italic> test</p>
      </caption>
      <graphic xlink:href="cddis2012193f1"/>
    </fig>
    <fig id="fig2">
      <label>Figure 2</label>
      <caption>
        <p>MYC was suppressed by selective GR isoforms. (<bold>a</bold>) Vehicle- or DEX- (100ânM, 24âh) treated cells showed reduction of MYC protein levels. RPLP was used as a loading control. The average (Â±S.E.M.) of three experiments are shown in the bar graph. *Significantly less than CON, <italic>P</italic>&lt;0.05, Student's <italic>t</italic>-test. (<bold>b</bold>) Time course of DEX regulation of MYC protein levels in GR-A- or -C3-expressing cells. MYC levels in GR-D3-expressing cells are shown as a control. (<bold>c</bold>) The role of MYC in DEX sensitivity. Ectopic expression of MYC increased the level of MYC in GR-C-expressing cells and MYCsi knocked down the expression level of MYC in GR-D-expressing cells. Ectopic expression of MYC partially protected, whereas knockdown of MYC sensitized the cells to DEX killing. *Significantly different, <italic>P</italic>&lt;0.05, Student's <italic>t</italic>-test. (<bold>d</bold>) Three IR-GREs (positions are relative to transcription start site) in the MYC regulatory region. (<bold>e</bold>) ChIP assays demonstrated that DEX (100ânM, 6âh) increased binding of all GR isoforms to two of the three MYC IR-GREs (underlined). *Significantly greater than CON, <italic>P</italic>&lt;0.05, Student's <italic>t</italic>-test, <italic>n</italic>=4 (Â±S.E.M.). (<bold>f</bold>) However, DEX reduced the amount of histone H4 acetylation and Pol II activation in cells expressing selective GR isoforms. *Significantly less than CON, <italic>P</italic>&lt;0.05, Student's <italic>t</italic>-test, <italic>n</italic>=4 (Â±S.E.M.)</p>
      </caption>
      <graphic xlink:href="cddis2012193f2"/>
    </fig>
    <fig id="fig3">
      <label>Figure 3</label>
      <caption>
        <p>BIM was induced by selective GR isoforms. Vehicle- or DEX- (100ânM, 24âh) treated cells showed induction of three forms of BIM proteins, EL, L, and S. The averages (Â±S.E.M.) of three experiments are shown in the bar graphs. *Significantly different, <italic>P</italic>&lt;0.05, ANOVA followed by Tukey's <italic>post hoc</italic> test</p>
      </caption>
      <graphic xlink:href="cddis2012193f3"/>
    </fig>
    <fig id="fig4">
      <label>Figure 4</label>
      <caption>
        <p>Real-time RT-PCR confirmation of cDNA microarray results. Averages (Â±S.E.M.) of at least three real-time RT-PCR experiments comparing vehicle (CON) or DEX (100ânM, 6âh) treatments. *Significantly different from CON, <italic>P</italic>&lt;0.05, Student's <italic>t</italic>-test</p>
      </caption>
      <graphic xlink:href="cddis2012193f4"/>
    </fig>
    <fig id="fig5">
      <label>Figure 5</label>
      <caption>
        <p>Facilitatory role of TUBA3E in apoptosis. (<bold>a</bold>) Verification of knockdown of TUBA3E (<italic>n</italic>=2, averageÂ±S.E.M.) in GR-C3-expressing cells and overexpression of TUBA3E in GR-D3-expressing cells. DEX, 100ânM, 6âh. *Significantly different, <italic>P</italic>&lt;0.05, ANOVA followed by Tukey's <italic>post hoc</italic> test. (<bold>b</bold>) DEX (100ânM, 48âh) sensitivity of cells with altered TUBA3E levels. Cell death was examined using PI staining (<italic>n</italic>=4, averageÂ±S.E.M.). *Significantly different, <italic>P</italic>&lt;0.05, ANOVA followed by Tukey's <italic>post hoc</italic> test. (<bold>c</bold>) Localization of tubulin (green) and TUBA3E (red) in GR-C-expressing cells treated with vehicle (CON) or DEX (100ânM, 6âh). Nuclei are indicated in blue (DAPI). Scale bar, 20â<italic>Î¼</italic>m</p>
      </caption>
      <graphic xlink:href="cddis2012193f5"/>
    </fig>
    <fig id="fig6">
      <label>Figure 6</label>
      <caption>
        <p>Selective expression of GR isoforms in primary T cells. (<bold>a</bold>) A representative western blot analysis of the GR isoforms in CD3+ T cells treated with ConA (7.5â<italic>Î¼</italic>g/ml, 0â5 days). Averages (<italic>n</italic>=3, averageÂ±S.E.M.) of the level of GR isoforms are shown in the line graph (*significantly greater than day 0, <italic>P</italic>&lt;0.05, one-way ANOVA followed by Tukey's <italic>post hoc</italic> tests, <italic>n</italic>=3) and the relative proportions of GR isoforms on day 3 are shown in the bar graph (*significantly greater than day 0, <italic>P</italic>&lt;0.05, Student's <italic>t</italic>-test, <italic>n</italic>=3, Â±S.E.M.). (<bold>b</bold>) DEX (100ânM or 1â<italic>Î¼</italic>M, 48âh) sensitivity of vehicle (CON) or ConA-treated cells as indicated by DAPI staining. *Significantly greater than CON, <italic>P</italic>&lt;0.05, one-way ANOVA followed by Tukey's <italic>post hoc</italic> tests, <italic>n</italic>=3, Â±S.E.M. (<bold>c</bold>) Real-time RT-PCR analysis of TUBA3E and AIM1 mRNA levels in vehicle (CON)- and DEX- (100ânM 6âh) treated control or ConA- (2.5â<italic>Î¼</italic>g/ml, 3 days) treated cells. *Significantly greater than CON, <italic>P</italic>&lt;0.05, one-way ANOVA followed by Tukey's <italic>post hoc</italic> tests, <italic>n</italic>=3, Â±S.E.M.</p>
      </caption>
      <graphic xlink:href="cddis2012193f6"/>
    </fig>
    <table-wrap id="tbl1">
      <label>Table 1</label>
      <caption>
        <title>Genes involved in apoptosis (GO: 0043067) and regulated by the GR-C3, but not the GR-D3, isoform</title>
      </caption>
      <table frame="hsides" rules="groups" border="1">
        <colgroup>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
          <col align="char" char="."/>
          <col align="char" char="."/>
        </colgroup>
        <thead valign="bottom">
          <tr>
            <th align="left" valign="top" charoff="50">
              <bold>Entrez i.d.</bold>
            </th>
            <th align="left" valign="top" charoff="50">
              <bold>Symbol</bold>
            </th>
            <th align="left" valign="top" charoff="50">
              <bold>Description</bold>
            </th>
            <th align="center" valign="top" char="." charoff="50">
              <bold>GR-C</bold>
            </th>
            <th align="center" valign="top" char="." charoff="50">
              <bold>GR-D</bold>
            </th>
          </tr>
        </thead>
        <tbody valign="top">
          <tr>
            <td colspan="3" align="center" valign="top" charoff="50">
              <italic>Induced (DEX/CON)</italic>
            </td>
            <td align="center" valign="top" char="." charoff="50"><italic>P</italic>&lt;0.01</td>
            <td align="center" valign="top" char="." charoff="50">NS</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â330</td>
            <td align="left" valign="top" charoff="50">
              <italic>BIRC3</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Baculoviral IAP repeat-containing 3</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">3.74</td>
            <td align="char" valign="top" char="." charoff="50">1.09</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â11â040</td>
            <td align="left" valign="top" charoff="50">
              <italic>PIM2</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Pim-2 oncogene</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">3.11</td>
            <td align="char" valign="top" char="." charoff="50">1.35</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â92â196</td>
            <td align="left" valign="top" charoff="50">
              <italic>DAPL1</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Death-associated protein-like 1</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">2.74</td>
            <td align="char" valign="top" char="." charoff="50">1.15</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â3708</td>
            <td align="left" valign="top" charoff="50">
              <italic>ITPR1</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Inositol 1,4,5-triphosphate receptor, type 1</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">2.39</td>
            <td align="char" valign="top" char="." charoff="50">1.17</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â9140</td>
            <td align="left" valign="top" charoff="50">
              <italic>ATG12</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Autophagy-related 12 homolog (S. cerevisiae)</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">2.36</td>
            <td align="char" valign="top" char="." charoff="50">1.16</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â27â242</td>
            <td align="left" valign="top" charoff="50">
              <italic>TNFRSF21</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Tumor necrosis factor receptor superfamily, member 21</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">2.16</td>
            <td align="char" valign="top" char="." charoff="50">1.20</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â3621</td>
            <td align="left" valign="top" charoff="50">
              <italic>ING1</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Inhibitor of growth family, member 1</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">2.07</td>
            <td align="char" valign="top" char="." charoff="50">1.28</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â23â513</td>
            <td align="left" valign="top" charoff="50">
              <italic>SCRIB</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Scribbled homolog (Drosophila)</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">2.01</td>
            <td align="char" valign="top" char="." charoff="50">1.30</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â3001</td>
            <td align="left" valign="top" charoff="50">
              <italic>GZMA</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">1.94</td>
            <td align="char" valign="top" char="." charoff="50">1.16</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â50â650</td>
            <td align="left" valign="top" charoff="50">
              <italic>ARHGEF3</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Rho guanine nucleotide exchange factor (GEF) 3</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">1.90</td>
            <td align="char" valign="top" char="." charoff="50">1.32</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â6446</td>
            <td align="left" valign="top" charoff="50">
              <italic>SGK1</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Serum/glucocorticoid-regulated kinase 1</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">1.89</td>
            <td align="char" valign="top" char="." charoff="50">1.34</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â11â214</td>
            <td align="left" valign="top" charoff="50">
              <italic>AKAP13</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>A kinase (PRKA) anchor protein 13</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">1.84</td>
            <td align="char" valign="top" char="." charoff="50">1.28</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â8531</td>
            <td align="left" valign="top" charoff="50">
              <italic>CSDA</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Cold-shock domain protein A</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">1.83</td>
            <td align="char" valign="top" char="." charoff="50">1.17</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â5295</td>
            <td align="left" valign="top" charoff="50">
              <italic>PIK3R1</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Phosphoinositide-3-kinase, regulatory subunit 1 (alpha)</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">1.81</td>
            <td align="char" valign="top" char="." charoff="50">1.24</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â10â018</td>
            <td align="left" valign="top" charoff="50">
              <italic>BCL2L11</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>BCL2-like 11 (apoptosis facilitator)</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">1.78</td>
            <td align="char" valign="top" char="." charoff="50">1.41</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â5590</td>
            <td align="left" valign="top" charoff="50">
              <italic>PRKCZ</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Protein kinase C, zeta</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">1.74</td>
            <td align="char" valign="top" char="." charoff="50">1.02</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â5921</td>
            <td align="left" valign="top" charoff="50">
              <italic>RASA1</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>RAS p21 protein activator (GTPase-activating protein) 1</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">1.72</td>
            <td align="char" valign="top" char="." charoff="50">1.45</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â7852</td>
            <td align="left" valign="top" charoff="50">
              <italic>CXCR4</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Chemokine (CâXâC motif) receptor 4</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">1.69</td>
            <td align="char" valign="top" char="." charoff="50">1.33</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â5728</td>
            <td align="left" valign="top" charoff="50">
              <italic>PTEN</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Phosphatase and tensin homolog (mutated in multiple advanced cancers 1)</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">1.65</td>
            <td align="char" valign="top" char="." charoff="50">â1.11</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â4908</td>
            <td align="left" valign="top" charoff="50">
              <italic>NTF3</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Neurotrophin 3</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">1.57</td>
            <td align="char" valign="top" char="." charoff="50">1.38</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â57â019</td>
            <td align="left" valign="top" charoff="50">
              <italic>CIAPIN1</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Cytokine-induced apoptosis inhibitor 1</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">1.56</td>
            <td align="char" valign="top" char="." charoff="50">1.07</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â10â276</td>
            <td align="left" valign="top" charoff="50">
              <italic>NET1</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Neuroepithelial cell transforming gene 1</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">1.56</td>
            <td align="char" valign="top" char="." charoff="50">â1.08</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â329</td>
            <td align="left" valign="top" charoff="50">
              <italic>BIRC2</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Baculoviral IAP repeat-containing 2</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">1.55</td>
            <td align="char" valign="top" char="." charoff="50">1.02</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â55â179</td>
            <td align="left" valign="top" charoff="50">
              <italic>FAIM</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Fas apoptotic inhibitory molecule</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">1.55</td>
            <td align="char" valign="top" char="." charoff="50">1.07</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â10â370</td>
            <td align="left" valign="top" charoff="50">
              <italic>CITED2</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy terminal domain, 2</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">1.51</td>
            <td align="char" valign="top" char="." charoff="50">1.28</td>
          </tr>
          <tr>
            <td colspan="5" align="left" valign="top" charoff="50">
              <italic>Repressed (DEX/CON)</italic>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â41â5116</td>
            <td align="left" valign="top" charoff="50">
              <italic>PIM3</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Pim-3 oncogene</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.53</td>
            <td align="char" valign="top" char="." charoff="50">1.07</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â60â675</td>
            <td align="left" valign="top" charoff="50">
              <italic>PROK2</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Prokineticin 2</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.53</td>
            <td align="char" valign="top" char="." charoff="50">â1.24</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â83â593</td>
            <td align="left" valign="top" charoff="50">
              <italic>RASSF5</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Ras association (RalGDS/AF-6) domain family member 5</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.55</td>
            <td align="char" valign="top" char="." charoff="50">â1.26</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â79â156</td>
            <td align="left" valign="top" charoff="50">
              <italic>PLEKHF1</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Pleckstrin homology domain containing, family F (with FYVE domain) member 1</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.56</td>
            <td align="char" valign="top" char="." charoff="50">â1.24</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â2769</td>
            <td align="left" valign="top" charoff="50">
              <italic>GNA15</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Guanine nucleotide-binding protein (G-protein), alpha 15 (Gq class)</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.66</td>
            <td align="char" valign="top" char="." charoff="50">â1.13</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â6304</td>
            <td align="left" valign="top" charoff="50">
              <italic>SATB1</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>SATB homeobox 1</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.83</td>
            <td align="char" valign="top" char="." charoff="50">â1.20</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â6659</td>
            <td align="left" valign="top" charoff="50">
              <italic>SOX4</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>SRY (sex determining region Y)-box 4</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.97</td>
            <td align="char" valign="top" char="." charoff="50">â1.14</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â1032</td>
            <td align="left" valign="top" charoff="50">
              <italic>CDKN2D</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.99</td>
            <td align="char" valign="top" char="." charoff="50">â1.18</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â5896</td>
            <td align="left" valign="top" charoff="50">
              <italic>RAG1</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Recombination activating gene 1</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â2.03</td>
            <td align="char" valign="top" char="." charoff="50">â1.12</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â4609</td>
            <td align="left" valign="top" charoff="50">
              <italic>MYC</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>v-Myc myelocytomatosis viral oncogene homolog (avian)</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â3.39</td>
            <td align="char" valign="top" char="." charoff="50">â1.32</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="t1-fn1">
          <p>Abbreviation: NS, not significant.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="tbl2">
      <label>Table 2</label>
      <caption>
        <title>Genes commonly repressed by the GR-C3 and -D3 isoforms in the presence of PMA and ionomycin</title>
      </caption>
      <table frame="hsides" rules="groups" border="1">
        <colgroup>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
          <col align="char" char="."/>
          <col align="char" char="."/>
        </colgroup>
        <thead valign="bottom">
          <tr>
            <th align="left" valign="top" charoff="50">
              <bold>Entrez i.d.</bold>
            </th>
            <th align="center" valign="top" charoff="50">
              <bold>Symbol</bold>
            </th>
            <th align="center" valign="top" charoff="50">
              <bold>Description</bold>
            </th>
            <th align="center" valign="top" char="." charoff="50">
              <bold>GR-C</bold>
            </th>
            <th align="center" valign="top" char="." charoff="50">
              <bold>GR-D</bold>
            </th>
          </tr>
        </thead>
        <tbody valign="top">
          <tr>
            <td colspan="3" align="left" valign="top" charoff="50">
              <italic>(PMA+ionomycin+DEX)/(PMA+ionomycin)</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50"><italic>P</italic>&lt;0.01</td>
            <td align="char" valign="top" char="." charoff="50"><italic>P</italic>&lt;0.01</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â4050</td>
            <td align="left" valign="top" charoff="50">
              <italic>LTB</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Lymphotoxin beta (TNF superfamily, member 3)</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â4.81</td>
            <td align="char" valign="top" char="." charoff="50">â3.07</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â3576</td>
            <td align="left" valign="top" charoff="50">
              <italic>IL-8</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Interleukin-8</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â8.25</td>
            <td align="char" valign="top" char="." charoff="50">â2.65</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â677</td>
            <td align="left" valign="top" charoff="50">
              <italic>ZFP36L1</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Zinc-finger protein 36, C3H-type-like 1</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â5.11</td>
            <td align="char" valign="top" char="." charoff="50">â2.57</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â4319</td>
            <td align="left" valign="top" charoff="50">
              <italic>MMP10</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Matrix metallopeptidase 10 (stromelysin 2)</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â2.58</td>
            <td align="char" valign="top" char="." charoff="50">â2.41</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â1026</td>
            <td align="left" valign="top" charoff="50">
              <italic>CDKN1A</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Cyclin-dependent kinase inhibitor 1A (p21, Cip1)</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â2.79</td>
            <td align="char" valign="top" char="." charoff="50">â2.36</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â8740</td>
            <td align="left" valign="top" charoff="50">
              <italic>TNFSF14</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Tumor necrosis factor (ligand) superfamily, member 14</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â2.21</td>
            <td align="char" valign="top" char="." charoff="50">â2.18</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â8743</td>
            <td align="left" valign="top" charoff="50">
              <italic>TNFSF10</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Tumor necrosis factor (ligand) superfamily, member 10</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.63</td>
            <td align="char" valign="top" char="." charoff="50">â2.18</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â6004</td>
            <td align="left" valign="top" charoff="50">
              <italic>RGS16</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Regulator of G-protein signaling 16</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â2.03</td>
            <td align="char" valign="top" char="." charoff="50">â2.15</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â79â156</td>
            <td align="left" valign="top" charoff="50">
              <italic>PLEKHF1</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Pleckstrin homology domain containing, family F (with FYVE domain) member 1</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.89</td>
            <td align="char" valign="top" char="." charoff="50">â2.02</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â1959</td>
            <td align="left" valign="top" charoff="50">
              <italic>EGR2</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Early growth response 2 (Krox-20homolog, Drosophila)</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â2.56</td>
            <td align="char" valign="top" char="." charoff="50">â2.02</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â50â617</td>
            <td align="left" valign="top" charoff="50">
              <italic>ATP6V0A4</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>ATPase, H+ transporting, lysosomal V0 subunit a4</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.54</td>
            <td align="char" valign="top" char="." charoff="50">â1.94</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â7124</td>
            <td align="left" valign="top" charoff="50">
              <italic>TNF</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Tumor necrosis factor (TNF superfamily, member 2)</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.72</td>
            <td align="char" valign="top" char="." charoff="50">â1.91</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â3002</td>
            <td align="left" valign="top" charoff="50">
              <italic>GZMB</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â5.23</td>
            <td align="char" valign="top" char="." charoff="50">â1.80</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â1647</td>
            <td align="left" valign="top" charoff="50">
              <italic>GADD45A</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Growth arrest and DNA-damage-inducible, alpha</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.71</td>
            <td align="char" valign="top" char="." charoff="50">â1.75</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â10â135</td>
            <td align="left" valign="top" charoff="50">
              <italic>NAMPT</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Nicotinamide phosphoribosyltransferase</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.90</td>
            <td align="char" valign="top" char="." charoff="50">â1.74</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â1437</td>
            <td align="left" valign="top" charoff="50">
              <italic>CSF2</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Colony-stimulating factor 2 (granulocyte-macrophage)</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.61</td>
            <td align="char" valign="top" char="." charoff="50">â1.73</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â2669</td>
            <td align="left" valign="top" charoff="50">
              <italic>GEM</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>GTP-binding protein overexpressed in skeletal muscle</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.90</td>
            <td align="char" valign="top" char="." charoff="50">â1.71</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â29â851</td>
            <td align="left" valign="top" charoff="50">
              <italic>ICOS</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Inducible T-cell costimulator</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.58</td>
            <td align="char" valign="top" char="." charoff="50">â1.71</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â4851</td>
            <td align="left" valign="top" charoff="50">
              <italic>NOTCH1</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Notch homolog 1, translocation-associated (Drosophila)</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.87</td>
            <td align="char" valign="top" char="." charoff="50">â1.70</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â3659</td>
            <td align="left" valign="top" charoff="50">
              <italic>IRF1</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Interferon regulatory factor 1</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â3.06</td>
            <td align="char" valign="top" char="." charoff="50">â1.69</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â22â822</td>
            <td align="left" valign="top" charoff="50">
              <italic>PHLDA1</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Pleckstrin homology-like domain, family A, member 1</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â4.65</td>
            <td align="char" valign="top" char="." charoff="50">â1.67</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â8459</td>
            <td align="left" valign="top" charoff="50">
              <italic>TPST2</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Tyrosylprotein sulfotransferase 2</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â2.68</td>
            <td align="char" valign="top" char="." charoff="50">â1.61</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â1649</td>
            <td align="left" valign="top" charoff="50">
              <italic>DDIT3</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>DNA-damage-inducible transcript 3</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â2.74</td>
            <td align="char" valign="top" char="." charoff="50">â1.61</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â2841</td>
            <td align="left" valign="top" charoff="50">
              <italic>GPR18</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>G-protein-coupled receptor 18</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.94</td>
            <td align="char" valign="top" char="." charoff="50">â1.57</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â3775</td>
            <td align="left" valign="top" charoff="50">
              <italic>KCNK1</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Potassium channel, subfamily K, member 1</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.80</td>
            <td align="char" valign="top" char="." charoff="50">â1.57</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â3399</td>
            <td align="left" valign="top" charoff="50">
              <italic>ID3</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Inhibitor of DNA-binding 3, dominant-negative helixâloopâhelix protein</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â2.56</td>
            <td align="char" valign="top" char="." charoff="50">â1.55</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â54â739</td>
            <td align="left" valign="top" charoff="50">
              <italic>XAF1</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>XIAP-associated factor 1</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.53</td>
            <td align="char" valign="top" char="." charoff="50">â1.55</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â444</td>
            <td align="left" valign="top" charoff="50">
              <italic>ASPH</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Aspartate beta-hydroxylase</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.52</td>
            <td align="char" valign="top" char="." charoff="50">â1.54</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â6304</td>
            <td align="left" valign="top" charoff="50">
              <italic>SATB1</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>SATB homeobox 1</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.84</td>
            <td align="char" valign="top" char="." charoff="50">â1.54</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â5366</td>
            <td align="left" valign="top" charoff="50">
              <italic>PMAIP1</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Phorbol-12-myristate-13-acetate-induced protein 1</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â2.35</td>
            <td align="char" valign="top" char="." charoff="50">â1.54</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â15â3769</td>
            <td align="left" valign="top" charoff="50">
              <italic>SH3RF2</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>SH3 domain-containing ring-finger 2</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.76</td>
            <td align="char" valign="top" char="." charoff="50">â1.53</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â2731</td>
            <td align="left" valign="top" charoff="50">
              <italic>GLDC</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Glycine dehydrogenase (decarboxylating)</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.83</td>
            <td align="char" valign="top" char="." charoff="50">â1.52</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â490</td>
            <td align="left" valign="top" charoff="50">
              <italic>ATP2B1</italic>
            </td>
            <td align="left" valign="top" charoff="50"><italic>ATPase, Ca</italic><sup><italic>2+</italic></sup>
<italic>transporting, plasma membrane 1</italic></td>
            <td align="char" valign="top" char="." charoff="50">â1.64</td>
            <td align="char" valign="top" char="." charoff="50">â1.51</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â51â561</td>
            <td align="left" valign="top" charoff="50">
              <italic>IL-23A</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Interleukin-23, alpha subunit p19</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â2.15</td>
            <td align="char" valign="top" char="." charoff="50">â1.51</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â3156</td>
            <td align="left" valign="top" charoff="50">
              <italic>HMGCR</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>3-Hydroxy-3-methylglutaryl-coenzyme A reductase</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.77</td>
            <td align="char" valign="top" char="." charoff="50">â1.51</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â8795</td>
            <td align="left" valign="top" charoff="50">
              <italic>TNFRSF10B</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Tumor necrosis factor receptor superfamily, member 10b</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.70</td>
            <td align="char" valign="top" char="." charoff="50">â1.50</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â326</td>
            <td align="left" valign="top" charoff="50">
              <italic>AIRE</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Autoimmune regulator</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.56</td>
            <td align="char" valign="top" char="." charoff="50">â1.50</td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">â26â191</td>
            <td align="left" valign="top" charoff="50">
              <italic>PTPN22</italic>
            </td>
            <td align="left" valign="top" charoff="50">
              <italic>Protein tyrosine phosphatase, non-receptor type 22 (lymphoid)</italic>
            </td>
            <td align="char" valign="top" char="." charoff="50">â1.50</td>
            <td align="char" valign="top" char="." charoff="50">â1.50</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
  </floats-group>
</article>

</metadata></record></GetRecord></OAI-PMH>